CG Oncology CGON
NASDAQ CGON
$73.44 +0.81 (+1.11%)
As of: Nov 11, 2026 · 10:15 AM EST

CG Oncology (CGON) Price to Book (2024 - 2026)

Updated

CG Oncology's (CGON) Price to Book stood at 6.10 in Q2 2026, up 106.2% from 2.96 a year earlier and up 11.7% from the prior quarter.

Analysis

CG Oncology (CGON) Price to Book (2024 - 2026) Analysis & Trends

For FY2025, CG Oncology's Price to Book came in at 4.45, up 82.1% from FY2024.

  • Across earlier years, Price to Book came in at 2.44 in FY2024.
  • The Q2 2026 figure is the highest quarterly Price to Book in data going back to Q1 2024.
  • On a year-over-year basis, Price to Book has increased for three consecutive quarters, with growth averaging 40.2% over the last six quarters.
  • Per Business Quant, the preceding three quarters came in at 5.46 (Q1 2026), 4.45 (Q4 2025) and 4.59 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 CG Oncology 6.49 Bn 2.66 Bn -1.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 6.39
Jun 30, 2026 6.10
Mar 31, 2026 5.46
Dec 31, 2025 4.45
Sep 30, 2025 4.59
Jun 30, 2025 2.96
Mar 31, 2025 2.65
Dec 31, 2024 2.44
Sep 30, 2024 4.75
Jun 30, 2024 3.81
Mar 31, 2024 3.63
API Access

CG Oncology Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=CGON&period=max&api_key=YOUR_API_KEY